MedPath

Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals

Completed
Conditions
Heart Failure
Hypertension
Registration Number
NCT02337790
Lead Sponsor
Baxter Healthcare Corporation
Brief Summary

This study is designed to validate the use of the CoVa Monitoring System in subjects with implanted devices.

Detailed Description

The study had the following objectives:

1. Verify that the CoVa Monitoring System does not interfere with implanted devices.

2. Verify that implanted devices do not interfere with the functions of the CoVa Monitoring System.

3. Verify that the CoVa Monitoring System fits on a wide variety of body types.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Subject is between 21 (twenty-one) and 95 (ninety-five) years of age at screening.
  • Subject has a pacemaker, implanted cardioverter-defibrillator, or ventricular assist device.
  • Subject and/or legally authorized person/representative is willing to undergo the Informed Consent process prior to enrollment in the study.
  • Subject is a candidate for this study based on the PI's opinion and knowledge of the subject's condition.
Exclusion Criteria
  • Subject is participating in another clinical study that may affect the results of either study.
  • Subject is unable or not willing to wear electrode patches as required.
  • Subject has skin sensitivity to adhesive or hydrogel materials used in electrode patches.
  • Subject is considered by the PI to be medically unsuitable for study participation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Patients with Interference between implanted devices and CoVa Monitoring SystemOne time for up to 15 minutes during a clinic visit for device interrogation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Imperial Cardiac Center

🇺🇸

Imperial, California, United States

© Copyright 2025. All Rights Reserved by MedPath